This E-mail is produced by AMEDEO through an unrestricted educational grant from Boehringer Ingelheim
1. AMEDEO HIV Infection
2011-04-04
2. The 2011 Short Guide to Hepatitis C (128 pages, PDF + ePub)
The book is available for download at www.FlyingPublisher.com .
If you are an expert in your field, please consider publishing a Flying Publisher Guide and reach out to a worldwide audience:
www.FlyingPublisher.com/publish.php (template files)
If not, start recommending your colleagues:
www.FlyingPublisher.com/recommend.php (see the 10% rule)
3. Free Books + 2000 Free Journals
Best regards,
Bernd Sebastian Kamps
________________ ** New articles ** _________________
1. PRAPARATTANAPAN J, Tragoolpua Y, Pathom-Aree W, Kotarathitithum W, et al.
Current Molecular Epidemiology and Recombination of HIV-1 Subtypes in Northern Thailand.
AIDS Res Hum Retroviruses. 2011.
ABSTRACT available
2. VERNON LT, Babineau DC, Demko CA, Lederman MM, et al.
A Prospective Cohort Study of Periodontal Disease Measures and Cardiovascular Disease Markers in HIV-Infected Adults.
AIDS Res Hum Retroviruses. 2011.
ABSTRACT available
3. MINHAS V, Crabtree KL, Chao A, Wojcicki JM, et al.
The Zambia Children's KS-HHV8 Study: Rationale, Study Design, and Study Methods.
Am J Epidemiol. 2011.
ABSTRACT available
4. TRABOULSI RS, Mukherjee PK, Chandra J, Salata RA, et al.
Gentian Violet Exhibits Activity against Biofilms formed by Oral Candida isolates
Obtained from HIV-infected Patients.
Antimicrob Agents Chemother. 2011.
ABSTRACT available
5. GOVENDER NP, Patel J, van Wyk M, Chiller TM, et al.
Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Obtained
Through Population-based Surveillance, South Africa, 2002-2003 and 2007-2008.
Antimicrob Agents Chemother. 2011.
ABSTRACT available
6. WANG L, Sun R, Eriksson S.
The Kinetic Effects on Thymidine Kinase 2 by Enzyme Bound dTTP May Explain
Mitochondrial Side Effects of Antiviral Thymidine Analogs.
Antimicrob Agents Chemother. 2011.
ABSTRACT available
7. CLAVEL C, Peytavin G, Tubiana R, Soulie C, et al.
Raltegravir Concentrations in the Genital Tract of HIV-1 infected Women Treated
with a raltegravir containing Regimen : DIVA 01 study.
Antimicrob Agents Chemother. 2011.
ABSTRACT available
8. LAM AM, Espiritu C, Murakami E, Zennou V, et al.
Inhibition of Hepatitis C Virus Replicon RNA Synthesis by PSI-352938, a Cyclic
Phosphate Prodrug of
{beta}-D-2'-Deoxy-2'-{alpha}-Fluoro-2'-{beta}-C-Methylguanosine.
Antimicrob Agents Chemother. 2011.
ABSTRACT available
9. HATHERILL M.
Prospects for elimination of childhood tuberculosis: the role of new vaccines.
Arch Dis Child. 2011.
ABSTRACT available
10. LIU Y, Timani K, Mantel C, Fan Y, et al.
Tip110/p110nrb/SART3/p110 regulation of hematopoiesis through c-Myc.
Blood. 2011.
ABSTRACT available
11. HODDER SL, Justman J, Haley DF, Adimora AA, et al.
Challenges of a hidden epidemic: HIV prevention among women in the United States.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S69-73.
ABSTRACT available
12. MILLETT GA, Crowley JS, Koh H, Valdiserri RO, et al.
A way forward: the National HIV/AIDS Strategy and reducing HIV incidence in the
United States.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S144-7.
ABSTRACT available
13. RABKIN M, El-Sadr WM, Mugyenyi P, Ramatlapeng MK, et al.
Lessons from Africa.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S141-3.
ABSTRACT available
14. NOWAK RG, Gravitt PE, Morrison CS, Gange SJ, et al.
Increases in Human Papillomavirus Detection During Early HIV Infection Among
Women in Zimbabwe.
J Infect Dis. 2011;203:1182-91.
ABSTRACT available
15. JAIN V, Sucupira MC, Bacchetti P, Hartogensis W, et al.
Differential Persistence of Transmitted HIV-1 Drug Resistance Mutation Classes.
J Infect Dis. 2011;203:1174-81.
ABSTRACT available
16. SPEARMAN P, Lally MA, Elizaga M, Montefiori D, et al.
A Trimeric, V2-Deleted HIV-1 Envelope Glycoprotein Vaccine Elicits Potent
Neutralizing Antibodies but Limited Breadth of Neutralization in Human
Volunteers.
J Infect Dis. 2011;203:1165-1173.
ABSTRACT available
17. KROWN SE, Dittmer DP, Cesarman E.
Pilot study of oral valganciclovir therapy in patients with classic kaposi
sarcoma.
J Infect Dis. 2011;203:1082-6.
ABSTRACT available
18. HAUT LH, Ratcliffe S, Pinto AR, Ertl H, et al.
Effect of preexisting immunity to adenovirus on transgene product-specific
genital T cell responses on vaccination of mice with a homologous vector.
J Infect Dis. 2011;203:1073-81.
ABSTRACT available
19. ASMAL M, Sun Y, Lane S, Yeh W, et al.
Antibody-dependent cell-mediated viral inhibition emerges after SIVmac251
infection of rhesus monkeys coincident with gp140 binding antibodies and is
effective against neutralization-resistant viruses.
J Virol. 2011.
ABSTRACT available
20. TOMITA Y, Noda T, Fujii K, Watanabe T, et al.
The cellular factors Vps18 and Mon2 are required for efficient production of
infectious HIV-1 particles.
J Virol. 2011.
ABSTRACT available
21. CHAHROUDI A, Meeker T, Lawson B, Ratcliffe S, et al.
Mother-to-infant transmission of SIV is rare in sooty mangabeys and is associated
with low viremia.
J Virol. 2011.
ABSTRACT available
22. ULLRICH A, Ott JJ, Vitoria M, Martin-Moreno JM, et al.
Long-term care of AIDS and non-communicable diseases.
Lancet. 2011;377:639-40.
23. LOURES L.
The fight is far from over.
Lancet. 2011;377:639.
24. MOSCOSO CG, Sun Y, Poon S, Xing L, et al.
Quaternary structures of HIV Env immunogen exhibit conformational vicissitudes
and interface diminution elicited by ligand binding.
Proc Natl Acad Sci U S A. 2011.
ABSTRACT available
25. NAVER L, Albert J, Belfrage E, Flamholc L, et al.
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish
Recommendations 2010.
Scand J Infect Dis. 2011.
ABSTRACT available
26. YUAN Y, Maeda Y, Terasawa H, Monde K, et al.
A combination of polymorphic mutations in V3 loop of HIV-1 gp120 can confer
noncompetitive resistance to maraviroc.
Virology. 2011.
ABSTRACT available
27. MOSZYNSKI P.
More needs to be done to tackle the "double cruelty" of HIV and TB in Africa,
says government.
BMJ. 2011;342:d1937.
28. MASCOLINI M, Mellors JW, Richman DD, Boucher CA, et al.
HIV and hepatitis virus resistance to antivirals: review of data from the XIX
International HIV and Hepatitis Virus Drug Resistance Workshop and Curative
Strategies.
Antivir Ther. 2011;16:263-86.
ABSTRACT available
29. BOYD SD, Maldarelli F, Sereti I, Ouedraogo GL, et al.
Transmitted raltegravir resistance in an HIV-1 CRF_AG-infected patient.
Antivir Ther. 2011;16:257-61.
ABSTRACT available
30. YOUNG B, Fransen S, Greenberg KS, Thomas A, et al.
Transmission of integrase strand-transfer inhibitor multidrug-resistant HIV-1:
case report and response to raltegravir-containing antiretroviral therapy.
Antivir Ther. 2011;16:253-6.
ABSTRACT available
31. WELZEN ME, van den Berk GE, Hamers RL, Burger DM, et al.
Interaction between antiretroviral drugs and acenocoumarol.
Antivir Ther. 2011;16:249-52.
ABSTRACT available
32. ARENAS-PINTO A, Grant A, Bhaskaran K, Copas A, et al.
Risk factors for fatality in HIV-infected patients with dideoxynucleoside-induced
severe hyperlactataemia or lactic acidosis.
Antivir Ther. 2011;16:219-226.
ABSTRACT available
33. THIBAULT V, Stitou H, Desire N, Valantin MA, et al.
Six-year follow-up of hepatitis B surface antigen concentrations in tenofovir
disoproxil fumarate treated HIV-HBV-coinfected patients.
Antivir Ther. 2011;16:199-205.
ABSTRACT available
34. POLSKY S, Floris-Moore M, Schoenbaum EE, Klein RS, et al.
Incident hyperglycaemia among older adults with or at-risk for HIV infection.
Antivir Ther. 2011;16:181-8.
ABSTRACT available
35. SEVINSKY H, Eley T, Persson A, Garner D, et al.
The effect of efavirenz on the pharmacokinetics of an oral contraceptive
containing ethinyl estradiol and norgestimate in healthy HIV-negative women.
Antivir Ther. 2011;16:149-56.
ABSTRACT available
36. HURT CB.
Transmitted resistance to HIV integrase strand-transfer inhibitors: right on
schedule.
Antivir Ther. 2011;16:137-40.
ABSTRACT available
37. Abstracts of the 17th Annual Conference of the British HIV Association (BHIVA).
April 6-8, 2011. Bournemouth, United Kingdom.
HIV Med. 2011;12 Suppl 1:1-91.
38. DE SOCIO G, Ricci E, Bonfanti P, Quirino T, et al.
Waist circumference and body mass index in HIV infection.
HIV Med. 2011;12:124-5.
_____________________ ** End ** ______________________
We have screened the following journals for you:
AIDS
AIDS Clin Care
AIDS Read
AIDS Res Hum Retroviruses
Am J Epidemiol
Am J Hematol
Am J Med
Ann Intern Med
Ann Neurol
Antimicrob Agents Chemother
Antivir Ther
Arch Dermatol
Arch Dis Child
Arch Intern Med
Arch Neurol
Blood
BMJ
Br J Dermatol
Br J Haematol
Cancer
Cell
Clin Infect Dis
Dermatology
Drugs
HIV Med
Immunology
Int J Cancer
Int J Dermatol
J Acquir Immune Defic Syndr
J Am Acad Dermatol
J Clin Immunol
J Clin Invest
J Clin Oncol
J Immunol
J Infect Dis
J Med Virol
J Pediatr
J Virol
JAMA
Lancet
MMWR
N Engl J Med
Nat Med
Nature
Neurology
Pediatr Infect Dis J
Pediatrics
Proc Natl Acad Sci U S A
Scand J Infect Dis
Science
Vaccine
Virology
_________________________________________________________
